The renal effects of nonsteroidal anti-inflammatory drugs in older people: Findings from the Established Populations for Epidemiologic Studies of the Elderly

Journal of the American Geriatrics Society

Volumn 47, Issue 5, 1999, Pages 507-511

  Field, Terry S ^a,b   Gurwitz, Jerry H ^a,b   Glynn, Robert J ^c,d   Salive, Marcel E ^e   Gaziano, J Michael ^d,f   Taylor, James O ^c,g   Hennekens, Charles H ^c,d  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e NATIONAL INSTITUTE ON AGING   (United States)

^f Massachusetts Veterans Epidemiology   (United States)

^g E Boston Neighborhood Health Center   (United States)

Author keywords

NSAIDs; Older people; Renal function; Serum creatinine

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT;

AGED; ARTICLE; CREATININE BLOOD LEVEL; FEMALE; FOLLOW UP; GERIATRIC PATIENT; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; PREVALENCE; UREA NITROGEN BLOOD LEVEL;

EID: 0032909684     PISSN: 00028614     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1532-5415.1999.tb02561.x     Document Type: Article

References (38)

1. Ray WA, Griffin MR, Avorn J. Evaluating drugs after their approval for clinical use. N Engl J Med 1993;329:2029-2032.
2. Chrischilles EA, Lemke JH, Wallace RB, Drube GA. Prevalence and characteristics of multiple analgesic drug use in an elderly study group. J Am Geriatr Soc 1990;38:979-984.
3. Cronin RE, Henrich WL. Toxic nephropathy. In: Brenner BM, ed. The Kidney, 5th Ed. Philadelphia: W.B. Saunders, 1995, pp 1696-1701.
4. Palmer BF, Levi M. Effect of aging on renal function and disease. In: Brenner BM, ed. The Kidney, 5th Ed. Philadelphia: W.B. Saunders, 1995, pp 2274-2291.
5. Lindeman RD, Tobin J, Shock NW. Longitudinal studies of decline in renal function with age. J Am Geriatr Soc 1985;33:278-285.
6. Gurwitz JH, Avorn J, Ross-Degnan D, Lipsitz LA. Nonsteroidal anti-inflammatory drug-associated azotemia in the very old. JAMA 1990;265: 471-475.
7. Blackshear JL, Davidman M, Stillman T. Identification of risk for renal insufficiency from nonsteroidal anti-inflammatory drugs. Arch Intern Med 1983;143:1130-1134.
8. Adams DH, Howie AJ, Michael J et al. Non-steroidal anti-inflammatory drugs and renal failure. Lancet 1986;i:57-60.
9. Sandler DP, Burr FR, Weinberg CR. Nonsteroidal anti-inflammatory drugs and the risk for chronic renal disease. Ann Intern Med 1991;115:165-172.
10. Henry D, Page J, Whyte I et al. Consumption of non-steroidal anti-inflammatory drugs and the development of functional renal impairment in elderly subjects. Results of a case-control study. Br J Clin Pharmacol 1997;44:85-90.
11. Murray MD, Black PK, Kuzmik DD et al. Acute and chronic effects of nonsteroidal antiinflammatory drugs on glomerular filtration rate in elderly patients. Am J Med Sci 1995;310:188-197.
12. Cornoni-Huntley J, Ostfeld AM, Taylor JO et al. Established populations for epidemiologic studies of the elderly: Study design and methodology. Aging: Clin Exp Res 1993;5:27-37.
13. Salive ME, Jones CA, Guralnik JM et al. Serum creatinine levels in older adults: Relationship with health status and medications. Age Ageing 1995; 24:142-150.
14. DeVito CA, Aldridge GW, Wilson A et al. Framework and development of a comprehensive drug product coding system. Contemp Pharm Proc 1979;2: 62-65.
15. Katz S, Akpom CA. A measure of primary sociobiological functions. Int J Health Serv 1976;6:493-508.
16. Branch LG, Katz S, Kniepmann K et al. A prospective study of functional status among community elders. Am J Public Health 1984;74:266-268.
17. Hypertension Detection and Follow-up Program Cooperative Group. Variability of blood pressure and the results of screening in the HDFP. J Chronic Dis 1978;31:651-667.
18. Bonney SL, Northington RS, Hedrich DA, Walker BR. Renal safety of two analgesics used over the counter: Ibuprofen and aspirin. Clin Pharmacol Ther 1986;40:373-377.
19. Fox DA, Jick H. Nonsteroidal anti-inflammatory drugs and renal disease. JAMA 1984;251:1299-1300.
20. Beard K, Perera DR, Jick H. Drug-induced parenchymal renal disease in out-patients. J Clin Pharmacol 1988;28:431-435.
21. Johnson JH, Jick H, Hunter JR, Dickson JF. A followup study of ibuprofen users. J Rheumatol 1985;12:549-552.
22. Morlans M, Laporte J, Vidal X et al. End-stage renal disease and non-narcotic analgesics: A case-control study. Br J Clin Pharmacol 1990;330: 717-723.
23. Perneger TV, Whelton PK, Klag MJ. Risk of kidney failure associated with the use of acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs. N Engl J Med 1994;331:1675-1679.
24. Segasothy M, Samad SA, Zulfigar A, Benett WM. Chronic renal disease and papillary necrosis associated with the long-term use of nonsteroidal antiinflammatory drugs as the sole or predominant analgesic. Am J Kidney Dis 1994;24:17-24.
25. Kleinknecht D, Landais P, Goldfarb B. Analgesic and non-steroidal antiinflammatory drug-associated acute renal failure: A prospective collaborative study. Clin Nephrol 1986;25:275-281.
26. Segasothy M, Chin GL, Sia KK et al. Chronic nephrotoxicity of antiinflammatory drugs used in the treatment of arthritis. Br J Rheumatol 1995; 34:162-165.
27. Calvo-Alen J, De Cos MA, Rodriguez-Valverde V et al. Subclinical renal toxicity in rheumatic patients receiving longterm treatment with nonsteroidal antiinflammatory drugs. J Rheumatol 1994;21:1742-1747.
28. Whelton A, Stout RL, Spilman PS, Klassen DK. Renal effects of ibuprofen, piroxicam, and sulindac in patients with asymptomatic renal failure: A prospective, randomized, crossover comparison. Ann Intern Med 1990;112: 568-576.
29. Evans WJ. What is sarcopenia? J Gerontol: Biol Sci Med Sci 1995;50: Spec:5-8.
30. Robbins J, Wahl P, Savage P et al. Hematological and biochemical laboratory values in older Cardiovascular Health Study participants. J Am Geriatr Soc 1995;43:855-859.
31. Carry PJ, Hunt WC, VanderJagt DJ, Rhyne RL. Clinical chemistry reference intervals for healthy elderly subjects. Am J Clin Nutr 1989;50:1219-1230.
32. Shulman NB, Ford CE, Hall WD et al. Prognostic value of serum creatinine and effect of treatment of hypertension on renal function: Results from the Hypertension Detection and Follow-up Program. Hypertension 1989; 13(suppl I):I80-93.
33. Damsgaard EM, Frøland A, Jørgensen OD, Mogenson CE. Microalbuminuria as predictor of increased mortality in elderly people. BMJ 1990;300:297-300.
34. Matts JP, Karnegis JN, Campos CT et al. Serum creatinine as an independent predictor of coronary heart disease mortality in normotensive survivors of myocardial infarction. J Fam Pract 1993;36:497-503.
35. Friedman PJ. Serum creatinine: An independent predictor of survival after stroke. J Intern Med 1991;229:175-179.
36. Wannamethee SG, Shaper AG, Perry IJ. Serum creatinine concentration and risk of cardiovascular disease: A possible marker for increased risk of stroke. Stroke 1997;28:557-563.
37. Clive DM, Stoff JS. Renal syndromes associated with nonsteroidal antiinflammatory drugs. N Engl J Med 1984;310:563-572.
38. Ciabattoni G, Cinotti GA, Pierucci A et al. Effects of sulindac and ibuprofen in patients with chronic glomerular disease: Evidence for the dependence of renal function on prostacyclin. N Engl J Med 1984;310:279-283.-